obesity drug news today glp-1 october 2025 therapies are changing care. What does WHO recommend? Here's what you need to know Obesity GLP-1 Market

Hayes MR, Borner T, De Jonghe BC

Analysis of Obesity GLP-1 Market by Key Country The obesity GLP-1 market is growing rapidly across major economies, with China and the United States both recording 25.4% CAGR through 2035, driven by large treatment-eligible populations and expanding access frameworks

But if I see someone who's lived with obesity for a long period of time, like years as we said, years living with obesity I'm going to pay very close attention to them about their disease risk

When theres more stuff in your blood in this case sugar and you suddenly reduce the amount of stuff in the blood, it causes rapid shifts in fluid between blood vessels and cells in the eye, he said

Heart rate as a risk factor for cardiovascular disease